CHROMOPHOBE RENAL CELL CARCINOMA
Clinical trials for CHROMOPHOBE RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CHROMOPHOBE RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CHROMOPHOBE RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New smart drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called NN3201, designed to find and attack cancer cells that have a specific protein called c-Kit. The trial includes people with advanced or spreading cancers like gastrointestinal stromal tumors (GIST), small-cell lung cancer, and others.…
Matched conditions: CHROMOPHOBE RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Novelty Nobility, Inc. • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
New drug cocktail targets rare cancers that have spread
Disease control Recruiting nowThis study is testing a combination of three drugs (cabozantinib, nivolumab, and ipilimumab) in people with rare cancers of the urinary and reproductive systems that have spread to other parts of the body. The goal is to see if this mix can shrink tumors better than any single dr…
Matched conditions: CHROMOPHOBE RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Scientists track Cancer's food choices in real time
Knowledge-focused Recruiting nowThis study looks at how kidney and bladder cancers use nutrients like sugar and fat to grow. About 600 adults having surgery or a biopsy will receive a special nutrient tracer through an IV. Blood and tissue samples are then analyzed to see how the cancer uses these fuels. Partic…
Matched conditions: CHROMOPHOBE RENAL CELL CARCINOMA
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC